Figure S7. (A-C) ELISA analysis of EGF, bFGF, IGF1, IGF2, NGF and HGF concentration in the supernatant of the indicated cells. (PDF 68Â kb
The relationship between miR-141-3p and clinicopathological characteristics in 141 patients with pro...
Figure S3. Real-time PCR analysis of miR-133a-3p expression in the indicated PC-3, C4-2B and VCaP ce...
miR-210-3p expression is upregulated in bone metastatic PCa tissues and cells. (a) Percentages and n...
Figure S6. Predicted miR-133a-3p targeting sequence and mutant sequences in 3â˛UTRs of EGFR, FGFR1,...
Table S3. The basic information of 20 paired prostate adenocarcinoma patients for miR-133a-3p expres...
Table S7. Univariate and multivariate analysis of factors associated with overall survival in 245 pa...
Table S5. The basic information of 245 prostate adenocarcinoma patients for miR-133a-3p expression a...
Table S8. Univariate and multivariate analysis of factors associated with bone metastasis free survi...
Table S4. The basic information of 48 patients with benign prostate lesions for miR-133a-3p expressi...
Table S2. A list of primers used in the reactions for real-time RT-PCR. (PDF 60Â kb
Figure S8. AKT signaling was essential for the pro-tumor roles of silencing miR-133a-3p in PCa cells...
Figure S2. Low expression of miR-133a-3p correlates with poor clinicopathological characteristics an...
Figure S1. miR-133a-3p is downregulated in PCa tissues. (A) miR-133a-3p expression levels was decrea...
Figure S4. (A and B) Real-time PCR of NANOG, BMI-1, SOX2 and OCT4 in the indicated cells. Transcript...
Figure S5. (A-C) Real-time PCR of BCL2, BCL-xL, Survivin and Mcl-1 in the indicated cells. Transcrip...
The relationship between miR-141-3p and clinicopathological characteristics in 141 patients with pro...
Figure S3. Real-time PCR analysis of miR-133a-3p expression in the indicated PC-3, C4-2B and VCaP ce...
miR-210-3p expression is upregulated in bone metastatic PCa tissues and cells. (a) Percentages and n...
Figure S6. Predicted miR-133a-3p targeting sequence and mutant sequences in 3â˛UTRs of EGFR, FGFR1,...
Table S3. The basic information of 20 paired prostate adenocarcinoma patients for miR-133a-3p expres...
Table S7. Univariate and multivariate analysis of factors associated with overall survival in 245 pa...
Table S5. The basic information of 245 prostate adenocarcinoma patients for miR-133a-3p expression a...
Table S8. Univariate and multivariate analysis of factors associated with bone metastasis free survi...
Table S4. The basic information of 48 patients with benign prostate lesions for miR-133a-3p expressi...
Table S2. A list of primers used in the reactions for real-time RT-PCR. (PDF 60Â kb
Figure S8. AKT signaling was essential for the pro-tumor roles of silencing miR-133a-3p in PCa cells...
Figure S2. Low expression of miR-133a-3p correlates with poor clinicopathological characteristics an...
Figure S1. miR-133a-3p is downregulated in PCa tissues. (A) miR-133a-3p expression levels was decrea...
Figure S4. (A and B) Real-time PCR of NANOG, BMI-1, SOX2 and OCT4 in the indicated cells. Transcript...
Figure S5. (A-C) Real-time PCR of BCL2, BCL-xL, Survivin and Mcl-1 in the indicated cells. Transcrip...
The relationship between miR-141-3p and clinicopathological characteristics in 141 patients with pro...
Figure S3. Real-time PCR analysis of miR-133a-3p expression in the indicated PC-3, C4-2B and VCaP ce...
miR-210-3p expression is upregulated in bone metastatic PCa tissues and cells. (a) Percentages and n...